Dalbavancin or oritavancin for skin infections

Comment

Helen W Boucher et al. N Engl J Med. 2014.

. 2014 Sep 18;371(12):1161-2.

doi: 10.1056/NEJMc1407925.

No abstract available

Comment on

Once-weekly dalbavancin versus daily conventional therapy for skin infection.
Boucher HW, Wilcox M, Talbot GH, Puttagunta S, Das AF, Dunne MW. Boucher HW, et al. N Engl J Med. 2014 Jun 5;370(23):2169-79. doi: 10.1056/NEJMoa1310480. N Engl J Med. 2014. PMID: 24897082 Clinical Trial.
Dalbavancin or oritavancin for skin infections.
Núñez-Núñez M, Rodríguez-Baño J. Núñez-Núñez M, et al. N Engl J Med. 2014 Sep 18;371(12):1160. doi: 10.1056/NEJMc1407925. N Engl J Med. 2014. PMID: 25229923 No abstract available.
Dalbavancin or oritavancin for skin infections.
Baang J, Fisher S. Baang J, et al. N Engl J Med. 2014 Sep 18;371(12):1160-1. doi: 10.1056/NEJMc1407925. N Engl J Med. 2014. PMID: 25229924 No abstract available.
Dalbavancin or oritavancin for skin infections.
Cormican M. Cormican M. N Engl J Med. 2014 Sep 18;371(12):1161. doi: 10.1056/NEJMc1407925. N Engl J Med. 2014. PMID: 25229925 No abstract available.